Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Antimicrobial chemotherapy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Roxithromycin in the therapy of Streptococcus pyogenes throat infections. Herron J M. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Nov 1987, vol. 20 Suppl B, p. 139−44, ISSN: 0305−7453.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26509
    Study title: A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis. Gaillat J. The Journal of antimicrobial chemotherapy, Mar 1993, vol. 31 Suppl C, p.139−51
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26473
    Study title: Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections. Wasilewski M M, Wilson M G, Sides G D, Stotka J L. The Journal of antimicrobial chemotherapy, Aug 2000, vol. 46, no. 2, p. 255 62
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26433
    Study title: Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. Schönwald S, Gunjaca M, Kolacny Babic L, Car V, Gosev M. The Journal of antimicrobial chemotherapy, Jan 1990, vol. 25 Suppl A, p.123−6.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26496
    Study title: Double−blind placebo−controlled trial of erythromycin in the treatment of clinical campylobacter infection. Mandal B K, Ellis M E, Dunbar E M, Whale K. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Jun 1984, vol. 13, no. 6, p.619−23, ISSN: 0305−7453.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26524
    Study title: Effect of phenoxymethylpenicillin and erythromycin prophylaxis on anaerobic bacteraemia after oral surgery. Josefsson K, Heimdahl A, von Konow L, Nord C E. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Aug 1985, vol. 16, no. 2, p.243−51, ISSN: 0305−7453.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26518
    Study title: Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts. Gordin A, Salmi HA, Antikainen R. The Journal of antimicrobial chemotherapy, , Jun 1988, vol. 21 Suppl D, p. 93−9
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26506
    Study title: Five day dirithromycin therapy is as effective as seven day erythromycin therapy for acute exacerbations of chronic bronchitis. Wasilewski M M, Johns D, Sides G D. The Journal of antimicrobial chemotherapy, Apr 1999, vol. 43, no. 4, p. 541 8
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26438
    Study title: Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787
    Active substance: TRIMETHOPRIM
    Study summary document link (including results):
    View full study record
    Document reference: 46780
    Study title: Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. Müller O, Wettich K. The Journal of antimicrobial chemotherapy, { Mar 1993, vol. 31 Suppl C, p. 97−102.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26472
    Study title: A comparison of Pivmecillinam and Co-trimoxazole in the treatment of simple cystitis in general practice; D. Guttmann, J of antimicrobial chemotherapy 1977, 3 suppl. B 137-140 A comparison of Pivmecillinam and Co-trimoxazole in the treatment of simple cystitis in general practice; D. Guttmann, J of antimicrobial chemotherapy 1977, 3 suppl. B 137-140
    Active substance: PIVMECILLINAM
    Study summary document link (including results):
    View full study record
    Document reference: 34528
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jun 18 08:01:21 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA